Erythrocyte CD38 as a prognostic marker in cancer

Hematology

Volumn 12, Issue 5, 2007, Pages 409-414

  Albeniz, Işil ^a   Demir, Özlem ^a   Türker Şener, Leyla ^a   Yalçintepe, Leman ^a   Nurten, Rüstem ^a   Bermek, Engin ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Cancer; CD38; CEA; Prognostic markers

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYL CYCLASE; CARCINOEMBRYONIC ANTIGEN; CD38 ANTIGEN; NICOTINAMIDE ADENINE DINUCLEOTIDE NUCLEOSIDASE;

ANEMIA; ANTIGEN EXPRESSION; ARTICLE; CANCER; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; HUMAN; HUMAN CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH; WESTERN BLOTTING;

ADP-RIBOSYL CYCLASE; ANEMIA; ANTIGENS, CD38; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DISEASE PROGRESSION; ERYTHROCYTES; HUMANS; NAD+ NUCLEOSIDASE; NEOPLASM PROTEINS; NEOPLASMS; PROGNOSIS; UP-REGULATION;

EID: 34748888950     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330701383841     Document Type: Article

References (47)

1. Pekala, PH and Anderson, BM (1982) Non-oxidation-reduction reactions of pyridine nucleotide. The pyridine nucleotide coenzymes, pp. 325-377. Academic Press, New York
2. Kim, H., Jacobson, EL and Jacobson, MK (1994) NAD glycohydrolases: A possible function in calcium homeostasis. Mol Cell Biochem, 138, pp. 237-243.
3. De Wolf, MJS, Van Dessel, GAF, Lagrou, AR, Hilderson, HJJ and Dierick, WSH (1985) Topography, purification and characterization of thyroidal NAD glycohydrolase. Biochem J, 226, pp. 415-427.
4. Zocchi, E., Franco, L., Guidea, L., Benatti, U., Bargellesi, A. and Malavasi, F. (1993) A single protein immunologically identified as CD38 displays NAD glycohydrolase, ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase activities at the outer surface of human erythrocytes. Biochem Biophys Res Commun, 196, pp. 1459-1465.
5. Malavasi, F., Funaro, A., Roggero, S., Horenstein, A., Calosso, L. and Mehta, K. (1994) Human CD38: A glycoprotein in search of a function. Immunol Today, 15, pp. 95-97.
6. Howard, M., Grimaldi, JC, Bazan, JF, Lund, FE, Santos-Argumedo, L. and Parkhouse, RME (1993) Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science, 262, pp. 1056-1059.
7. Takasawa, S., Togho, A., Noguchi, N., Koguma, T., Nata, K. and Sugimoto, T. (1993) Synthesis and hydrolysis of cyclic ADP-ribose by human leukocyte antigen CD38 and inhibition of the hydrolysis by ATP. J Biol Chem, 268, pp. 26052-26054.
8. Kim, H., Jacobson, EL and Jacobson, MK (1993) Synthesis and degradation of cyclic ADP-ribose by NAD glycohydrolases. Science, 261, pp. 1330-1333.
9. Muller-Steffner, HM, Augustine, A. and Schuber, F. (1996) Mechanism of cyclization of pyridine nucleotides by bovine spleen NAD+ glycohydrolase. J Biol Chem, 271, pp. 23967-23972.
10. Moss, J. and Vaughan, M. (1998) ADP-ribosylation of guanyl nucleotide binding regulatory proteins by bacterial toxins. Adv Enzymol, 61, pp. 303-379.
11. Mehta, K., Shahid, U. and Malavasi, F. (1996) Human CD38, a cell-surface protein with multiple functions. FASEB J, 10, pp. 1408-1417.
12. Lund, F., Solvason, N., Grimaldi, JC, Parkhouse, RME and Howard, M. (1995) Murine CD38: An immunoregulatory ectoenzyme. Immunol Today, 16, pp. 469-473.
13. Kim, UH, Han, MK, Park, BH, Kim, HR and An, NH (1993) Function of NAD glycohydrolase in ADP-ribose uptake from NAD by human erythrocytes. Biochim Biophys Acta, 1178, pp. 121-128.
14. Albeniz, I., Demir, &, Nurten, R. and Bermek, E. (2004) NAD glycohydrolase activities and ADP-ribose uptake in erythrocytes from normal subjects and cancer patients. Biosci Rep, 24, pp. 41-53.
15. Harlow, E. and Lane, D. (1988) A laboratory manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
16. Prall, YG, Gambhir, KK and Ampy, FR (1998) Acetyl cholinesterase: An enzymatic marker of human red blood cell aging. Life Sci, 63, pp. 177-184.
17. Graeff, RM, Walseth, TF, Fryxell, K., Branton, WD and Lee, HC (1994) Enzymatic synthesis and characterization of cyclic GDP-ribose. A procedure for distinguishing enzymes with ADP-ribosyl cyclase activity. J Biol Chem, 269, pp. 30260-30267.
18. Laemmli, UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, pp. 680-685.
19. Gershoni, JM and Palade, GE (1983) Protein blotting: Principles and applications. Anal Biochem, 131, pp. 1-15.
20. Deaglio, S., Mehta, K. and Malavasi, F. (2001) Human CD38: A (r)evolutionary story of enzymes and receptors. Leuk Res, 25, pp. 1-12.
21. Kontani, K., Nishina, H., Ohoka, Y., Takahashi, K. and Katada, T. (1993) NAD glycohydrolase specifically induced by retinoic acid in human leukemic HL-60 cells. Identification of the NAD glycohydrolase as leukocyte cell surface antigen CD38. J Biol Chem, 268, pp. 16895-16898.
22. Yalcintepe, L., Ercelen, S., Adin-Cinar, S., Badur, S., Tiryaki, D. and Bermek, E. (2003) Hemin-dependent induction and internalization of CD38 in K562 cells. J Cell Biochem, 90, pp. 379-386.
23. Daugas, E., Cande, C. and Kroemer, G. (2001) Erythrocytes: Death of a mummy. Cell Death Differ, 8, pp. 1131-1133.
24. Umar, S., Malavasi, F. and Mehta, K. (1996) Post-translational modification of CD38 protein into a high molecular weight form alters its catalytic properties. J Biol Chem, 271, pp. 15922-15929.
25. Matutes, E. (2002) New additions to antibody panels in the characterisation of chronic lymphoproliferative disorders. J Clin Path, 55, pp. 180-183.
26. Watson, JM, Sensintaffar, JL, Berek, JS and Martinez-Maza, O. (1990) Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res, 50, pp. 6959-6965.
27. Siegall, CB, Schwab, G., Nordan, RP, FitzGerald, DJ and Pastan, I. (1990) Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells. Cancer Res, 50, pp. 7786-7788.
28. Shim, KS, Kim, KH, Han, WS and Park, EB (1999) Elevated serum levels of transforming growth factor-beta1 in patients with colorectal carcinoma: Its association with tumor progression and its significant decrease after curative surgical resection. Cancer, 85, pp. 554-561.
29. Elaraj, DM, Weinreich, DM, Varghese, S., Puhlmann, M., Hewitt, SM and Caroll, NM (2006) The role of interleukin 1 in growth and metastasis of human cancer xenografts. Clin Cancer Res, 12, pp. 1088-1096.
30. Bendre, MS, Margulies, AG, Walser, B., Akel, NS, Bhattacharrya, SR and Skinner, A. (2005) Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway. Cancer Res, 65, pp. 11001-11009.
31. Lahm, H., Wyniger, J., Hertig, S., Yilmaz, A., Fischer, JR and Givel, JC (1994) Secretion of bioactive granulocyte-macrophage colony-stimulating factor by human colorectal carcinoma cells. Cancer Res, 54, pp. 3700-3702.
32. Blay, JY, Negrier, S., Comaret, V., Attali, S., Goillot, E. and Merrouche, Y. (1992) Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res, 52, pp. 3317-3322.
33. Michalaki, V., Syrigos, K., Charles, P. and Waxman, J. (2004) Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer. Br J Cancer, 90, pp. 2312-2316.
34. Wise, GJ, Marella, VK, Talluri, G. and Shirazian, D. (2000) Cytokine variations in patients with hormone treated prostate cancer. J Urol, 164, pp. 722-725.
35. Zhang, GJ and Adachi, I. (1999) Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res, 19, pp. 1427-1432.
36. Galizia, G., Lieto, E., De Vita, F., Romano, C., Orditura, M. and Castellano, P. (2002) Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: Relationship with radicality and outcome. J Interferon Cytokine Res, 22, pp. 473-482.
37. Scambia, G., Testa, U., Benedetti, P., Foti, E., Martucci, R. and Gadducci, A. (1995) Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer. Br J Cancer, 71, pp. 354-356.
38. Nisio, M Di, Niers, TM, Reitsma, PH and Buller, HR (2005) Plasma cytokine and P-selectin levels in advanced malignancy: Prognostic value and impact of low-molecular weight heparin administration. Cancer, 104, pp. 2275-2281.
39. Macri, A., Versaci, A., Loddo, S., Scuderi, G., Travagliante, M. and Trimarchi, G. (2006) Serum levels of interleukin 1beta, interleukin 8 and tumour necrosis factor alpha as markers of gastric cancer. Biomarkers, 11, pp. 184-193.
40. Mroczko, B., Szmitkowski, M. and Okulczyk, B. (2003) Hematopoietic growth factors in colorectal cancer patients. Clin Chem Lab Med, 41, pp. 646-651.
41. Coussens, LM and Werb, Z. (2002) Inflammation and cancer. Nature, 420, pp. 860-867.
42. Hedin, KE (2002) Chemokines: New, key players in the pathobiology of pancreatic cancer. Int J Gastrointest Cancer, 31, pp. 23-29.
43. Rollins, BJ (2006) Inflammatory Chemokines in cancer growth and progression. Eur J Cancer, 42, pp. 760-767.
44. Ruegg, C. (2006) Leukocytes, inflammation, and angiogenesis in cancer: Fatal attractions. J Leukoc Biol, 80, pp. 682-684.
45. Lande, R., Urbani, F., Carlo, B Di, Sconocchia, G., Deaglio, S. and Funaro, A. (2002) CD38 ligation plays a direct role in the induction of IL-1beta, IL-6, and IL-10 secretion in resting human monocytes. Cell Immunol, 220, pp. 30-38.
46. Ceyhan, BB, Demiralp, E. and Çelikel, T. (1996) Analysis of pleural effusion using flow cytometry. Respiration, 63, pp. 17-24.
47. Ceyhan, BB, Özgün, S., Çelikel, T., Yaliçn, M. and Koç, M. (1996) IL-8 in pleural effusion. Resp Med, 90, pp. 215-221.